Our HIV-1 RT-PCR kits utilize reverse transcription polymerase chain reaction (RT-PCR) technology, which converts the viral RNA into complementary DNA (cDNA) followed by PCR amplification to detect and quantify the viral load.

Our HLA-B27 RT-PCR kits offer high sensitivity and specificity, enabling accurate detection and monitoring of HLA-B27 gene expression

Our TB qPCR kits are specifically designed to detect Mycobacterium tuberculosis (Mtb). Our kits amplify specific nucleic acid sequences unique to Mtb and quantify the amount of DNA present in the sample. By detecting and quantifying Mtb DNA, these kits provide a highly sensitive and specific method for diagnosing tuberculosis and monitoring treatment response.

Our HBV qPCR kit amplifies specific nucleic acid sequences unique to HBV and quantify the amount of viral DNA present in the sample. By detecting and quantifying HBV DNA, these kits provide a highly sensitive and specific method for diagnosing HBV infection, monitoring viral load, assessing treatment response, and predicting disease progression.

Our HCV RT-PCR kit is designed for the detection and quantification of Hepatitis C virus (HCV) RNA in clinical samples. By detecting and quantifying HCV RNA, these kits provide a highly sensitive and specific method for diagnosing HCV infection, monitoring viral load, assessing treatment response, and predicting disease progression.

Our HPV 16/18 kit can be used for detection and quantification of HPV types 16 and 18 DNA in clinical samples. The kit amplifies specific nucleic acid sequences unique to HPV 16 and HPV 18 and quantify the amount of viral DNA present in the sample. kits provide a highly sensitive and specific method for identifying high-risk HPV infections, particularly those associated with the development of cervical cancer and other HPV-related cancers.